SOPHiA GENETICS (SOPH) Cost of Revenue (2020 - 2025)

SOPHiA GENETICS (SOPH) has 6 years of Cost of Revenue data on file, last reported at $7.0 million in Q4 2025.

• For the quarter ending Q4 2025, Cost of Revenue rose 24.58% year-over-year to $7.0 million; the trailing twelve-month figure through Dec 2025 stood at $25.2 million (up 18.64% YoY), and the FY2025 full-year result was $25.2 million, up 18.64% from the prior year.
• Cost of Revenue grew to $7.0 million in Q4 2025, from $6.6 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $7.0 million in Q4 2025 to a low of $3.4 million in Q1 2021.
• A 5-year average of $4.9 million and a median of $5.0 million in 2023 frame the typical range for Cost of Revenue.
• Peak annual rise in Cost of Revenue reached 131406.38% in 2021, while the deepest fall reached 99.8% in 2021.
• Tracing SOPH's Cost of Revenue over 5 years: stood at $4.1 million in 2021, then retreated by 8.62% to $3.8 million in 2022, then surged by 37.22% to $5.1 million in 2023, then climbed by 9.34% to $5.6 million in 2024, then grew by 24.58% to $7.0 million in 2025.
• Business Quant data shows SOPH's Cost of Revenue at $7.0 million in Q4 2025, $6.6 million in Q3 2025, and $6.1 million in Q2 2025.